1-20 of 23
Section: Coronary artery disease
Save search
Sort by
Journal Article

Polygenic risk, aspirin, and primary prevention of coronary artery disease

PDF
Chenglong Yu and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 11, Issue 1, January 2025, Pages 84–91, https://doi.org/10.1093/ehjcvp/pvae085
Published: 25 October 2024
Journal Article

Phosphodiesterase 5 and its inhibitors with ischaemic heart disease: a Mendelian randomization analysis and a real-world study

PDF
Jun Xiao and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 11, Issue 1, January 2025, Pages 75–83, https://doi.org/10.1093/ehjcvp/pvae081
Published: 18 October 2024
Journal Article

Impact of ticagrelor with or without aspirin on total and recurrent bleeding and ischaemic events after percutaneous coronary intervention: a sub-study of the TWILIGHT trial

PDF
Usman Baber and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 11, Issue 1, January 2025, Pages 66–74, https://doi.org/10.1093/ehjcvp/pvae080
Published: 17 October 2024
Journal Article

2024 ESC guidelines on chronic coronary syndromes: what is new in pharmacotherapy?

PDF
Mattia Galli and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 10, Issue 7, November 2024, Pages 572–574, https://doi.org/10.1093/ehjcvp/pvae069
Published: 17 September 2024
Journal Article

Effects of albiglutide on myocardial infarction and ischaemic heart disease outcomes in patients with type 2 diabetes and cardiovascular disease in the Harmony Outcomes trial

PDF
Konstantin A Krychtiuk and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 10, Issue 4, July 2024, Pages 279–288, https://doi.org/10.1093/ehjcvp/pvae006
Published: 25 January 2024
Journal Article

Combination therapy with moderate-intensity atorvastatin and ezetimibe vs. high-intensity atorvastatin monotherapy in patients treated with percutaneous coronary intervention in practice: assessing RACING generalizability

PDF
Seung-Jun Lee and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 10, Issue 8, December 2024, Pages 676–685, https://doi.org/10.1093/ehjcvp/pvad083
Published: 10 November 2023
Journal Article

Characteristics and outcomes in patients with a prior myocardial infarction treated with extended dual antiplatelet therapy with ticagrelor 60 mg: findings from ALETHEIA, a multi-country observational study

PDF
M P Bonaca and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 9, Issue 8, December 2023, Pages 701–708, https://doi.org/10.1093/ehjcvp/pvad062
Published: 31 August 2023
Journal Article

Bioinformatic platforms for clinical stratification of natural history of atherosclerotic cardiovascular diseases

PDF
Giuditta Benincasa and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 9, Issue 8, December 2023, Pages 758–769, https://doi.org/10.1093/ehjcvp/pvad059
Published: 10 August 2023
Journal Article

The effect of discontinuing beta-blockers after different treatment durations following acute myocardial infarction in optimally treated, stable patients without heart failure: a Danish, nationwide cohort study

PDF
Andrim Halili and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 9, Issue 6, September 2023, Pages 553–561, https://doi.org/10.1093/ehjcvp/pvad046
Published: 30 June 2023
Journal Article

Finerenone efficacy in patients with chronic kidney disease, type 2 diabetes and atherosclerotic cardiovascular disease

PDF
Gerasimos Filippatos and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 9, Issue 1, January 2023, Pages 85–93, https://doi.org/10.1093/ehjcvp/pvac054
Published: 17 October 2022
Journal Article

Cost–effectiveness of ticagrelor in patients with type 2 diabetes and coronary artery disease: a European economic evaluation of the THEMIS trial

PDF
Philippe Gabriel Steg and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 8, Issue 8, December 2022, Pages 777–785, https://doi.org/10.1093/ehjcvp/pvac032
Published: 30 April 2022
Journal Article

Antiplatelet effect, safety, and pharmacokinetics of vicagrel in patients with coronary artery disease undergoing percutaneous coronary intervention

PDF
Xin Zhao and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 8, Issue 8, December 2022, Pages 806–814, https://doi.org/10.1093/ehjcvp/pvac026
Published: 19 April 2022
Journal Article

Long-Term Treatment with the Combination of Rivaroxaban and Aspirin in Patients with Chronic Coronary or Peripheral Artery Disease: Outcomes During the Open Label Extension of the COMPASS trial

PDF
John W Eikelboom and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 8, Issue 8, December 2022, Pages 786–795, https://doi.org/10.1093/ehjcvp/pvac023
Published: 06 April 2022
Journal Article

Extended, standard, or De-escalation antiplatelet therapy for patients with coronary artery disease undergoing percutaneous coronary intervention? A trial-sequential, bivariate, influential, and network meta-analysis

PDF
Waqas Ullah and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 8, Issue 7, November 2022, Pages 717–727, https://doi.org/10.1093/ehjcvp/pvac020
Published: 24 March 2022
Journal Article

Association of guideline-directed medical therapy adherence with outcomes after fractional flow reserve-based deferral of revascularization

PDF
Masanobu Ishii and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 8, Issue 6, October 2022, Pages 600–608, https://doi.org/10.1093/ehjcvp/pvac008
Published: 02 February 2022
Journal Article

Impact of white blood cell count on clinical outcomes in patients treated with aspirin-free ticagrelor monotherapy after percutaneous coronary intervention: insights from the GLOBAL LEADERS trial

PDF
Masafumi Ono and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 8, Issue 1, January 2022, Pages 39–47, https://doi.org/10.1093/ehjcvp/pvaa110
Published: 21 September 2020
Journal Article

Meta-analysis of studies examining the external validity of the dual antiplatelet therapy score

PDF
Guy Witberg and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 6, Issue 5, September 2020, Pages 285–291, https://doi.org/10.1093/ehjcvp/pvz075
Published: 03 December 2019
Journal Article

Efficacy and safety with ticagrelor in patients with prior myocardial infarction in the approved European label: insights from PEGASUS-TIMI 54

PDF
Mikael Dellborg and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 5, Issue 4, October 2019, Pages 200–206, https://doi.org/10.1093/ehjcvp/pvz020
Published: 20 June 2019
Journal Article

External applicability of the COMPASS trial: the Western Denmark Heart Registry

PDF
Morten Würtz and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 5, Issue 4, October 2019, Pages 192–199, https://doi.org/10.1093/ehjcvp/pvz013
Published: 27 March 2019
Journal Article

Coronary artery disease severity and long-term cardiovascular risk in patients with myocardial infarction: a Danish nationwide register-based cohort study

PDF
Cengiz Özcan and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 4, Issue 1, January 2018, Pages 25–35, https://doi.org/10.1093/ehjcvp/pvx009
Published: 21 April 2017